Recep Çalışkan | Aortic Aneurysm | Innovative Research Award

Published on by Global Genetics Award

Innovative Research Award

Recep Çalışkan
Turkish Ministry of Health, Turkey

Recep Çalışkan
Affiliation Turkish Ministry of Health
Country Turkey
Scopus ID 59967569100
Documents 5
Subject Area Aortic Aneurysm
Event Global Genetics Awards

Recep Çalışkan is a researcher affiliated with the Turkish Ministry of Health whose documented scholarly profile includes five Scopus-indexed documents. His stated subject area is aortic aneurysm, a clinically important field encompassing the investigation, diagnosis, management, and prevention of pathological enlargement of the aortic wall. The profile is presented in connection with the Innovative Research Award of the Genetics Awards.[1]

Abstract

This academic recognition profile presents the research record of Recep Çalışkan, affiliated with the Turkish Ministry of Health and associated with research in aortic aneurysm. The available bibliometric information identifies five documents indexed in Scopus and provides a researcher identifier for bibliographic discovery. Aortic aneurysm research is multidisciplinary and can involve vascular biology, cardiovascular medicine, diagnostic imaging, surgical treatment, endovascular intervention, and risk-factor assessment. The available information supports recognition of a research profile in this subject area while avoiding conclusions about citation performance or h-index because those metrics were not supplied in the source profile.[1]

Keywords

Aortic aneurysm; cardiovascular research; vascular medicine; vascular disease; clinical research; medical research; Turkish Ministry of Health; Scopus; research recognition; Innovative Research Award.

Introduction

Aortic aneurysms are abnormal dilatations of the aorta that may remain clinically silent for substantial periods but can become life-threatening when complications such as rupture or dissection occur. Research in this field therefore encompasses mechanisms of vascular-wall degeneration, identification of risk factors, imaging-based surveillance, medical management, and procedural interventions. Contemporary management increasingly relies on multidisciplinary approaches combining clinical assessment, imaging, risk stratification, and individualized treatment decisions .[1]

Within this broader scientific context, a researcher profile associated with aortic aneurysm research may contribute to improved understanding of disease mechanisms, clinical decision-making, diagnostic strategies, or treatment pathways. The present page summarizes the information supplied for Recep Çalışkan and distinguishes documented bibliometric information from metrics that were not provided.

Research Profile

Recep Çalışkan is affiliated with the Turkish Ministry of Health, Turkey. The supplied bibliometric profile associates the researcher with Scopus author identifier 59967569100 and records five documents. The stated specialization is aortic aneurysm, placing the profile within cardiovascular and vascular research. The available information does not provide a verified citation count, h-index, or ORCID identifier; these fields are therefore not assigned numerical or identification values in this article.

The Scopus identifier provides a useful route for locating the researcher’s indexed scholarly record and distinguishing the profile from researchers with similar names. Bibliometric interpretation should nevertheless consider publication context, authorship, journal scope, citation practices, and the date on which the profile is assessed .[2]

Research Contributions

Based on the supplied subject classification, Çalışkan’s research profile is situated in the field of aortic aneurysm. Research in this area can contribute to the understanding and management of clinically significant vascular disorders through several interconnected domains:

  • Clinical characterization and risk assessment of patients with aortic aneurysmal disease.
  • Evaluation of diagnostic and imaging approaches used for disease detection and surveillance.
  • Investigation of vascular and cardiovascular factors associated with aneurysm development or progression.
  • Assessment of clinical and procedural strategies relevant to contemporary aneurysm management.

These domains represent the broader scientific context of the stated subject area rather than claims that every listed activity has been demonstrated in the researcher’s five indexed documents. A detailed assessment of individual contributions would require examination of the publications themselves.

Publications

The supplied profile reports 5 documents associated with the Scopus author identifier 59967569100. The individual publication titles, journal names, publication years, citation counts, and DOI identifiers were not provided in the input data. Accordingly, no specific publication titles are attributed to Çalışkan in this article without bibliographic verification.[1]

Research Impact

Research impact can be evaluated through multiple complementary indicators, including scholarly publications, citations, clinical relevance, collaboration, methodological contributions, and translation into practice. The supplied profile confirms five Scopus-indexed documents but does not provide a citation total or h-index. Consequently, quantitative claims about citation impact cannot be made reliably from the available information.

In the context of aortic aneurysm research, potential impact may be reflected in contributions to disease recognition, clinical evidence, diagnostic assessment, patient management, or understanding of vascular pathology. Such impact should be evaluated against verified publication-level evidence and appropriate bibliometric benchmarks rather than inferred solely from the number of documents. [2]

Award Suitability

The supplied profile provides a reasonable academic basis for consideration under an Innovative Research Award in the area of aortic aneurysm because it identifies a defined research specialization, an institutional affiliation, and a documented Scopus-indexed publication record of five documents. These characteristics establish an identifiable scholarly profile relevant to the award’s research-oriented scope.[1]

A final award assessment should additionally consider the originality of the research, quality and relevance of the publications, evidence of methodological or clinical innovation, citation performance, collaboration, societal or clinical relevance, and independent recognition. Since several of these indicators were not supplied, this page presents award suitability as a profile-based assessment rather than a definitive ranking.

Conclusion

Recep Çalışkan is presented as a researcher affiliated with the Turkish Ministry of Health whose stated research area is aortic aneurysm. The supplied record identifies five Scopus documents and a Scopus author identifier, providing a basis for further bibliographic review. The profile is relevant to the research-focused scope of the Genetics Awards’ Innovative Research Award, while a comprehensive evaluation would require verification of publication-level evidence, citations, research originality, and measurable clinical or scientific impact.

References

  1. Association of Ascending Aortic Aneurysm with NOX4 and miRNA 146a
    https://www.mdpi.com/2073-4425/17/6/709

  2. An Exploratory Machine Learning Analysis of 10-Year Mortality After Isolated CABG
    https://onlinelibrary.wiley.com/doi/10.1155/jocs/3088313

  3. Minimally Invasive Coronary Arter Bypass Grafting
    https://books.akademisyen.net/index.php/akya/catalog/book/3544/chapter/6131

  4. Minimally Invasive Heart Surgery
    https://books.akademisyen.net/index.php/akya/catalog/book/3544

Magdalena Serrano | Retrovirus infection in sheep | Innovative Research Award

Published on by Global Genetics Award

Innovative Research Award

Magdalena Serrano
INIA-CSIC
Magdalena Serrano
Affiliation INIA-CSIC
Country Spain
Scopus ID 7201394133
Documents 76
Citations 1,514
h-index 23
Subject Area Retrovirus infection in sheep
Event Global Genetics Awards
ORCID 0000-0002-1621-3102

Magdalena Serrano, affiliated with INIA-CSIC in Spain, is recognized in this academic profile for research associated with retrovirus infection in sheep. The recognition is presented under the Innovative Research Award category of the Genetics Awards. The supplied bibliometric record reports 76 documents, 1,514 citations, and an h-index of 23, providing quantitative indicators of research visibility and scholarly influence within the indexed scientific literature.[1]

Abstract

This academic recognition profile presents Magdalena Serrano and her research context at INIA-CSIC, Spain, with a subject-area focus on retrovirus infection in sheep. Research on small-ruminant retroviruses encompasses molecular epidemiology, host–virus interactions, pathogenesis, immune responses, diagnosis, and the genetic factors that can influence disease expression. These areas are relevant to animal health, livestock production, veterinary biotechnology, and the development of evidence-based strategies for controlling infectious diseases in sheep. The reported bibliometric indicators of 76 documents, 1,514 citations, and an h-index of 23 are included as supplied measures of scholarly output and citation impact.[1]

Keywords

  • Retrovirus infection
  • Sheep health
  • Small-ruminant lentiviruses
  • Animal genetics
  • Veterinary virology
  • Host–virus interactions

Introduction

Small-ruminant lentiviruses are retroviruses that affect sheep and goats and include viruses associated with chronic inflammatory disease. In sheep, infection with visna-maedi virus can produce progressive pulmonary, neurological, mammary, and articular manifestations. The biological characteristics of these infections make host susceptibility, immune response, viral variation, and transmission important areas of investigation. Reviews of small-ruminant lentiviruses have emphasized the value of integrating molecular, immunological, epidemiological, and veterinary approaches when studying these infections. [1][2]

Research Profile

The supplied research profile places Magdalena Serrano within the scientific context of INIA-CSIC and identifies retrovirus infection in sheep as the principal subject area for this recognition. This area intersects veterinary medicine, animal genetics, infectious-disease biology, and livestock health. Studies of retroviral infection in small ruminants commonly require integration of laboratory investigation with population-level and host-level analysis because disease outcome can depend on viral characteristics, host responses, environmental factors, and patterns of transmission. [1]

The profile’s reported Scopus record identifies 76 documents, 1,514 citations, and an h-index of 23. These figures are reproduced from the information supplied for the recognition page and should be understood as bibliometric indicators that can change as indexing databases are updated.

Research Contributions

Research concerning retrovirus infection in sheep contributes to understanding the biological mechanisms underlying persistent infection and disease progression. Small-ruminant lentiviruses are characterized by their ability to establish long-term infections, making questions concerning viral replication, immune evasion, tissue tropism, and host responses particularly relevant. [1][2]

From an animal-health perspective, research in this domain can support improved detection and epidemiological surveillance while providing scientific evidence for approaches to disease control. The integration of genetics with infectious-disease research is also relevant to identifying host factors that may influence infection or clinical outcome, although specific genetic associations should be interpreted according to the evidence presented in individual studies.

  • Investigation of retroviral infections affecting sheep and other small ruminants.
  • Study of host–virus relationships relevant to persistent infection and disease.
  • Application of genetic and veterinary perspectives to livestock infectious-disease research.
  • Contribution to scientific knowledge relevant to surveillance, diagnosis, and animal-health management.

Publications

The supplied Scopus record attributes 76 indexed documents to the researcher profile. Because individual publication titles and publication-level metadata were not provided in the source information for this page, this section does not assign specific papers to Magdalena Serrano without independent bibliographic verification. The subject-area literature, however, provides an established scientific context for research on small-ruminant lentiviruses and their effects in sheep. [1][2]

Research Impact

The supplied bibliometric record reports 1,514 citations across 76 documents and an h-index of 23. These measures indicate that the indexed body of work has received substantial scholarly attention. Citation-based metrics are useful for describing research visibility, but they do not independently measure the quality, originality, societal relevance, or practical value of individual publications.

In the context of animal infectious-disease research, scientific impact can also be reflected through contributions to disease understanding, diagnostic methodologies, epidemiological knowledge, animal-health policy, and the development of future research directions. Consequently, bibliometric indicators are most appropriately considered alongside the scientific content and documented contributions of the research record.

Award Suitability

Based on the information supplied for this recognition profile, Magdalena Serrano is presented as a candidate for the Innovative Research Award within the Genetics Awards. The stated specialization in retrovirus infection in sheep provides a clear scientific focus at the intersection of animal genetics, veterinary virology, and infectious-disease research. The reported record of 76 documents, 1,514 citations, and an h-index of 23 further provides quantitative evidence of an established indexed publication record.

Award suitability should ultimately be determined through review of the candidate’s verified publications, originality of research findings, methodological contributions, scientific influence, and relevance to the award’s formal criteria. The available information supports presenting the profile for consideration but does not, by itself, constitute an independent assessment of award eligibility or comparative ranking.

Conclusion

Magdalena Serrano’s recognition profile is centered on research concerning retrovirus infection in sheep and is affiliated with INIA-CSIC in Spain. The supplied bibliometric indicators—76 documents, 1,514 citations, and an h-index of 23—describe a substantial indexed research record. Within the broader scientific literature, research on small-ruminant lentiviruses remains relevant to understanding persistent viral infections, host responses, animal health, and disease-control strategies. [1][2]

References

  1. Amplicon sequencing with Oxford nanopore technologies as a diagnostic alternative for small ruminant lentiviruses in sheep
    https://www.nature.com/articles/s41598-026-36989-y
  2. Phylogenetic relationships and genetic conservation status of a Creole sheep population
    https://www.sciencedirect.com/science/article/pii/S1751731126001205
  3. RNA-Seq Analysis of Human Cumulus Cells Identifies Angiogenic Pathways Associated with Infertility
    https://www.mdpi.com/2073-4409/15/8/677
  4. Shifts in the vaginal microbiota of nulliparous ewe lambs following initial reproductive handling and estrus synchronization
    https://academic.oup.com/jas/article/doi/10.1093/jas/skag184/8703277

 

Xiaoya Liu | Neuroengineering | Best Researcher Award

Published on by Global Genetics Award

Best Researcher Award

Xiaoya Liu
Tianjin University, China

Xiaoya Liu
Affiliation Tianjin University
Country China
Scopus ID 57204178405
Documents 42
Citations 477
h-index 13
Subject Area Neuroengineering
Event Genetics Awards

Xiaoya Liu is a researcher affiliated with Tianjin University in China whose stated subject area is Neuroengineering. The academic recognition profile presented here concerns the Best Researcher Award associated with the Genetics Awards event. The supplied research metrics comprise 42 documents, 477 citations, and an h-index of 13. These indicators provide a bibliometric snapshot of scholarly output and citation activity and should be interpreted in relation to field, career stage, publication practices, and the underlying indexing database. [1]

Abstract

This academic recognition profile presents Xiaoya Liu of Tianjin University, China, in connection with the Best Researcher Award under the Genetics Awards event. Liu’s stated research specialization is Neuroengineering. The supplied bibliometric record reports 42 documents, 477 citations, and an h-index of 13. These metrics indicate a documented body of indexed scholarly work and citation activity. Bibliometric indicators are quantitative measures and do not, by themselves, describe the full scientific significance, methodological quality, societal relevance, or originality of an individual researcher’s work. [1]

Keywords

  • Xiaoya Liu
  • Tianjin University
  • Neuroengineering
  • Best Researcher Award
  • Genetics Awards
  • Research impact
  • Bibliometrics

Introduction

Neuroengineering is an interdisciplinary research area that connects neuroscience and engineering with methods from fields such as biomedical engineering, electrical engineering, computer science, materials science, and related disciplines. Research in this area can involve the development or application of technologies for investigating neural systems, recording and interpreting neural signals, designing interfaces between biological and engineered systems, and supporting neurological research and applications.

Within this context, the profile of Xiaoya Liu is associated with Tianjin University and the subject area of Neuroengineering. The bibliometric information supplied for this profile provides quantitative indicators that can be used to describe the research record while recognizing that citation-based measures vary according to discipline, database coverage, publication type, and time period.  [1]

Research Profile

Researcher Xiaoya Liu
Institution Tianjin University
Country China
Subject Area Neuroengineering
Documents 42
Citations 477
h-index 13
Award Category Best Researcher Award

The supplied profile identifies Tianjin University as Liu’s institutional affiliation and Neuroengineering as the principal subject area. The reported Scopus identifier provides a route to the indexed author record, while the reported documents, citations, and h-index summarize selected bibliometric characteristics of the research profile. [1]

Research Contributions

The available information identifies Neuroengineering as Liu’s subject area but does not provide a verified publication-by-publication description of specific research projects, technologies, datasets, or experimental findings. Accordingly, this profile does not attribute particular discoveries or technical contributions beyond the supplied field classification. A detailed assessment of research contributions would require examination of the researcher’s publications, research projects, patents, conference contributions, and other primary scholarly records.

From an academic-profile perspective, the reported record of 42 indexed documents provides a quantitative basis for identifying an established publication portfolio. The citation count of 477 and h-index of 13 offer additional indicators of scholarly visibility within the relevant indexing environment. [1]

Publications

The supplied information does not include a verified list of individual publication titles, journals, publication years, co-authors, or digital object identifiers (DOIs). Therefore, no individual publication or DOI is attributed to Xiaoya Liu in this section without a corresponding source. The indexed author record can be consulted for bibliographic information and publication-level details. [1]

  • Reported indexed documents: 42.
  • Reported citations: 477.
  • Reported h-index: 13.
  • Individual DOI information: not supplied in the source data provided for this profile.

Research Impact

The supplied bibliometric indicators show 477 citations associated with 42 documents and an h-index of 13. These measures can be used as quantitative indicators of citation activity and publication performance within the indexed record. However, bibliometric values should not be treated as standalone measures of research quality or societal impact because citation behavior differs among disciplines and because databases may differ in coverage and author disambiguation.

A fuller assessment of research impact would consider the content and originality of the work, methodological rigor, influence on subsequent research, collaborations, technological or clinical translation where applicable, and evidence of broader academic or societal use. Such dimensions are not contained in the supplied numerical indicators and therefore are not independently characterized here.

Award Suitability

For the Best Researcher Award profile associated with Genetics Awards, the available information establishes several documented elements relevant to an academic recognition record: an affiliation with Tianjin University, a stated specialization in Neuroengineering, 42 reported documents, 477 reported citations, and an h-index of 13.

These indicators can form part of an award-review dossier, but they do not independently establish award eligibility or determine the outcome of an award process. A comprehensive recognition assessment would ordinarily require the applicable award criteria, verified publication records, research contributions, peer-reviewed evidence, and any additional materials specified by the organizing body.

Conclusion

Xiaoya Liu is presented in this academic recognition profile as a Tianjin University researcher in China working in the stated area of Neuroengineering. The supplied bibliometric record reports 42 documents, 477 citations, and an h-index of 13. These indicators provide a concise quantitative description of the indexed research record. Further evaluation of Liu’s scholarly contributions and recognition for the Best Researcher Award would require detailed review of primary publications, research outputs, and the formal criteria applied by the relevant award program.

References

  1. Scopus. Author profile associated with Scopus Author ID 57204178405. The supplied profile data identifies 42 documents, 477 citations, and an h-index of 13. Available at:
    https://www.scopus.com/authid/detail.uri?authorId=57204178405.

  2. Naturalistic facial dynamics enable quantitative clinical assessment of atypical expression phenotypes in children with autism spectrum disorder
    https://www.nature.com/articles/s41746-026-02375-1

  3. Multidimensional Acoustic–Prosodic Quantification Framework Using Unscripted Speech for Autism Spectrum Disorder Identification
    https://onlinelibrary.wiley.com/doi/abs/10.1002/aur.70206

  4. Cross-subject emotion recognition with loop adaptive adversarial transfer network
    https://www.sciencedirect.com/science/article/pii/S0893608025012055

 

Melisa Kafali | Single-Cell Transcriptomics | Innovative Research Award

Published on by Global Genetics Award

Innovative Research Award

Melisa Kafali
University of Arizona, United States

Melisa Kafali
Affiliation University of Arizona
Country United States
Scopus ID 58295947300
Documents 3
Citations 21
h-index 2
Subject Area Single-Cell Transcriptomics
Event Global Genetics Awards
ORCID 0000-0002-9281-548X

Melisa Kafali is a researcher affiliated with the University of Arizona whose stated subject area is single-cell transcriptomics. Her academic recognition profile identifies her for consideration for the Innovative Research Award at the Genetics Awards. The available bibliometric information records 3 documents, 21 citations, and an h-index of 2, providing a quantitative snapshot of her indexed research activity. [1]

The profile also identifies an ORCID record associated with Melisa Kafali, providing a persistent researcher identifier that can assist with distinguishing scholarly work and maintaining accurate attribution across research systems. [2]

Abstract

This article presents an academic recognition profile for Melisa Kafali, a researcher affiliated with the University of Arizona and working in the subject area of single-cell transcriptomics. The profile is associated with the Innovative Research Award category within the Genetics Awards event. Available bibliometric information reports 3 indexed documents, 21 citations, and an h-index of 2. [1] These indicators provide a concise quantitative description of the research output and scholarly visibility represented in the supplied profile.

Single-cell transcriptomics is a research approach concerned with examining gene-expression patterns at the level of individual cells. Within this broad field, research profiles may encompass the generation, analysis, interpretation, and integration of high-resolution transcriptomic datasets. The available information for Kafali identifies the field of specialization but does not provide sufficient publication-level details to attribute particular discoveries, datasets, methods, or biological findings without additional primary sources.

Keywords

  • Melisa Kafali
  • Innovative Research Award
  • Single-Cell Transcriptomics
  • Genetics Awards
  • University of Arizona
  • Transcriptomic Research
  • Single-Cell Analysis
  • Genomics

Introduction

Single-cell transcriptomics has become an important area of contemporary molecular and genomic research because it enables gene-expression patterns to be investigated at cellular rather than solely population-averaged resolution. This approach can help researchers characterize cellular heterogeneity, identify transcriptionally distinct populations, and investigate changes in cellular states. Its application requires integration of experimental procedures with computational and statistical approaches for processing and interpreting high-dimensional biological data.

Against this scientific background, an academic profile in single-cell transcriptomics can be evaluated through multiple dimensions, including research output, scholarly visibility, methodological development, reproducibility, collaboration, and contribution to the interpretation of biological systems. For the present recognition profile, the supplied bibliometric record provides evidence of indexed scholarly activity, while the stated research area establishes the principal disciplinary context. [1]

Research Profile

Melisa Kafali is identified as being affiliated with the University of Arizona in the United States. Her stated subject area is single-cell transcriptomics, placing the profile within the broader fields of transcriptomics, genomics, molecular biology, and computational analysis of biological data.

The supplied bibliometric information lists 3 documents, 21 citations, and an h-index of 2. These figures are useful indicators of indexed research activity and citation visibility, although bibliometric measures should be interpreted in relation to career stage, publication chronology, field-specific citation practices, authorship patterns, and the coverage of the underlying database. [1]

An ORCID identifier is also provided for the researcher. ORCID identifiers are designed to provide persistent and unique identification for researchers and can support accurate association of scholarly contributions with an individual researcher. [2]

Research Contributions

The supplied information places Kafali’s research within single-cell transcriptomics, a discipline that can contribute to a more detailed understanding of cellular diversity and gene-expression regulation. Research in this area commonly involves the production or analysis of transcriptomic profiles from individual cells and the subsequent identification of biologically meaningful cellular populations and transcriptional states.

On the basis of the available information, the principal documented contribution that can be described without speculation is participation in scholarly research within this specialized field. The available bibliometric record indicates that this research has resulted in indexed documents and has received citations from subsequent scholarly work. [1] Specific methodological innovations, biological discoveries, datasets, or software contributions should be assessed from individual publications and primary research records rather than inferred solely from citation metrics.

Publications

The supplied profile reports 3 documents indexed in Scopus. [1] However, the input data does not provide individual publication titles, journal names, publication years, author lists, or article-level DOI identifiers. Consequently, no specific publication or DOI is attributed to Kafali in this article without independent bibliographic verification.

For publication-level assessment, the appropriate sources include the researcher’s indexed author record and persistent ORCID identifier. These resources can be used to cross-check authorship, publication metadata, and researcher attribution before individual works are added to an academic profile. [1] [2]

Research Impact

The supplied citation profile records 21 citations across 3 documents and an h-index of 2. [1] These metrics indicate that the indexed publications have received measurable scholarly attention. Citation counts, however, are descriptive indicators rather than direct measures of research quality, and their interpretation should account for disciplinary differences and the time available for publications to accumulate citations.

Within single-cell transcriptomics, research impact may be reflected through methodological reproducibility, adoption of analytical approaches, contribution to biological interpretation, data reuse, interdisciplinary collaboration, and citation by subsequent research. A complete assessment of Kafali’s impact would therefore require examination of the underlying publications and their contexts of use in addition to the bibliometric indicators supplied here.

Award Suitability

Melisa Kafali is presented for consideration in the Innovative Research Award category of the Genetics Awards, with single-cell transcriptomics identified as the relevant subject area. The field itself is strongly associated with the development and application of high-resolution approaches for investigating cellular transcriptional states, making it an appropriate disciplinary context for an innovation-oriented research recognition.

The available record provides several objective elements relevant to an academic recognition profile: an institutional affiliation at the University of Arizona, a defined research specialization, 3 indexed documents, 21 citations, and an h-index of 2. [1] These indicators establish a documented research presence but should not, by themselves, be interpreted as proof of a particular scientific innovation.

For a rigorous award assessment, the strongest supporting evidence would consist of verified publication-level contributions, clearly documented methodological or conceptual advances, evidence of research adoption or reuse, and independent scholarly recognition. The supplied profile provides a foundation for such an assessment while avoiding unsupported attribution of specific discoveries.

Conclusion

Melisa Kafali is an academic researcher affiliated with the University of Arizona whose stated specialization is single-cell transcriptomics. The available profile records 3 documents, 21 citations, and an h-index of 2, providing a concise bibliometric representation of her indexed scholarly activity. [1]

The Innovative Research Award profile recognizes research activity within a technically significant area of modern genomics and transcriptomics. A complete evaluation of scientific innovation should combine bibliometric evidence with direct examination of publications, methods, datasets, and documented research outcomes. The information presented here therefore distinguishes between verified profile information and claims that would require additional publication-level evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Melisa Kafali, Author ID 58295947300. Scopus.https://www.scopus.com/authid/detail.uri?authorId=58295947300
  2. ORCID. (n.d.). ORCID record: Melisa Kafali, ORCID iD 0000-0002-9281-548X. ORCID.https://orcid.org/0000-0002-9281-548X
  3. Antibacterial properties and osteoblast interactions of microfluidically synthesized chitosan–SPION composite nanoparticles.
    https://onlinelibrary.wiley.com/doi/full/10.1002/jbm.a.37575
  4. Google Scholar. (n.d.). Google Scholar profile supplied for the researcher. Google.https://scholar.google.com/citations?user=1GpZgRQAAAAJ&hl=en&oi=sra
  5. Multifunctional POSS-based nanoparticles functionalized with silver, SPIONs, and rhamnolipid for antibacterial applications.
    https://www.sciencedirect.com/science/article/pii/S2772950825005059

Y.M.R.C. Hirushan | Rehabilitation | Innovative Research Award

Published on by Global Genetics Award

Innovative Research Award

Y.M.R.C. Hirushan
Jiangwan Hospital of Hongkou, China
Y.M.R.C. Hirushan
Affiliation Jiangwan Hospital of Hongkou
Country China
Subject Area Rehabilitation
Event Global Genetics Awards
ORCID 0009-0006-3635-7505

Y.M.R.C. Hirushan is associated with Jiangwan Hospital of Hongkou in China and is identified for recognition under the Innovative Research Award in the field of Rehabilitation at the Genetics Awards. Based on the information supplied for this recognition profile, the award consideration focuses on the researcher’s professional association with rehabilitation research and its broader relevance to evidence-based approaches for improving health, function, participation, and quality of life. Rehabilitation is a multidisciplinary field that integrates clinical, scientific, technological, and social approaches to optimize functioning and reduce disability across health conditions. [1]

Abstract

This academic recognition profile presents Y.M.R.C. Hirushan, affiliated with Jiangwan Hospital of Hongkou, China, as a candidate for the Innovative Research Award in Rehabilitation at the Genetics Awards. Rehabilitation research encompasses interventions and strategies intended to optimize functioning and participation while addressing disability associated with disease, injury, ageing, and other health conditions. [1] The available nomination information identifies Rehabilitation as the principal subject area and provides an ORCID identifier for researcher-level scholarly identification. Because detailed publication, citation, Scopus, and project records were not supplied, this profile deliberately avoids attributing specific publications, numerical bibliometric achievements, or individual research findings that cannot be independently established from the provided information.

Keywords

  • Rehabilitation
  • Innovative Research
  • Rehabilitation Research
  • Health and Function
  • Disability and Participation
  • Genetics Awards

Introduction

Rehabilitation is recognized internationally as an important component of health systems because it aims to optimize functioning and independence and to support participation in everyday life. The World Health Organization describes rehabilitation as a set of interventions designed to optimize functioning and reduce disability in interaction with an individual’s health condition and environment. [1] Contemporary rehabilitation therefore extends beyond a single clinical discipline and may involve physical, occupational, cognitive, communication, technological, psychosocial, and community-based approaches.

Research and innovation within rehabilitation are important for developing interventions that are effective, accessible, measurable, and responsive to individual needs. Evidence-based rehabilitation emphasizes the integration of high-quality research evidence with clinical expertise and the circumstances and preferences of individuals receiving care. [2] Within this context, recognition of researchers working in rehabilitation can provide an opportunity to highlight contributions to scientific inquiry, clinical knowledge, methodological development, and the translation of research into improved practice.

Research Profile

Y.M.R.C. Hirushan is listed in the supplied award information as being affiliated with Jiangwan Hospital of Hongkou, China, with Rehabilitation designated as the subject area. The profile is associated with the Genetics Awards and the Innovative Research Award category. An ORCID identifier, 0009-0006-3635-7505, is provided as the principal persistent researcher identifier.

No verified Scopus identifier, publication count, citation count, h-index, detailed research project list, or publication bibliography was included in the supplied nomination data. Accordingly, those fields are marked as not provided in the infobox rather than being estimated or inferred. This approach maintains a distinction between documented profile information and information requiring additional bibliographic verification.

Research Contributions

The supplied information establishes Rehabilitation as the principal area associated with this recognition profile, but it does not provide sufficient detail to assign specific experimental findings or named research programs to Y.M.R.C. Hirushan. A responsible academic profile should therefore distinguish the broader scientific context of rehabilitation from individually documented achievements.

From a field perspective, important areas of rehabilitation research include the evaluation of interventions, measurement of functional outcomes, development of assistive technologies, prevention and management of disability, restoration of physical and cognitive function, and strategies supporting long-term participation. Systematic reviews and evidence-based frameworks are commonly used to assess the effectiveness and applicability of rehabilitation interventions. [2][3]

  • Application of evidence-based approaches to rehabilitation practice and research.
  • Development and evaluation of interventions intended to improve functioning and participation.
  • Use of scientifically appropriate outcome measures to evaluate rehabilitation results.
  • Integration of multidisciplinary perspectives in rehabilitation research.

Publications

A verified list of publications authored by Y.M.R.C. Hirushan was not included in the supplied award information. Consequently, no individual journal article, conference paper, book chapter, citation count, or DOI is attributed to the researcher on this page. This avoids the risk of incorrectly associating similarly named researchers or publications with the award candidate. [1]

For publication verification, researcher-level identifiers such as ORCID can be used alongside bibliographic databases and publisher records. The supplied ORCID profile provides a persistent identifier that can assist in distinguishing the researcher from other authors with similar names.

Research Impact

The potential impact of rehabilitation research can be assessed through several complementary dimensions, including scientific contribution, methodological quality, clinical relevance, implementation in healthcare settings, patient and community outcomes, and influence on rehabilitation policy and practice. The World Health Organization emphasizes rehabilitation as an essential health service and describes its relevance to functioning across the life course. [1]

For Y.M.R.C. Hirushan, the available information confirms the disciplinary and institutional context of the nomination but does not provide sufficient bibliometric or outcome data to quantify individual research impact. Future documentation of peer-reviewed publications, research projects, collaborations, citations, implementation outcomes, or other verifiable scholarly indicators would allow a more comprehensive assessment.

Award Suitability

The Innovative Research Award profile is aligned with the supplied subject classification of Rehabilitation and the institutional affiliation with Jiangwan Hospital of Hongkou. Rehabilitation is inherently multidisciplinary and depends on continued innovation in clinical methods, technologies, assessment approaches, and models of care. [1][3] On the information available, the nomination can appropriately be described as a recognition profile within rehabilitation rather than as an independently verified account of specific scientific achievements.

A rigorous award assessment would ordinarily consider the originality of research, methodological quality, peer-reviewed scholarly output, reproducibility, practical relevance, collaboration, dissemination, and measurable influence on the field. Where such evidence is available, these dimensions can provide a structured basis for evaluating research recognition. The present profile records the supplied affiliation, country, subject area, event, and ORCID information without introducing unsupported performance claims.

Conclusion

Y.M.R.C. Hirushan is presented in the supplied nomination information as a researcher affiliated with Jiangwan Hospital of Hongkou, China, in the field of Rehabilitation and under consideration for the Innovative Research Award at the Genetics Awards. Rehabilitation is a scientifically and clinically significant discipline focused on optimizing functioning and reducing disability. [1] The profile provides an ORCID identifier for researcher identification, while detailed bibliometric and publication information remains unspecified. Further verified scholarly records would strengthen the documentation of individual research contributions and impact.

References

  1. Y.M.R.C. Hirushan is presented Profile Verified in Orcid:
    https://orcid.org/0009-0006-3635-7505.
  2. Negrini S, Kiekens C, et al. Evidence-based rehabilitation and the importance of integrating research evidence with clinical expertise and patient circumstances. The principles of evidence-based practice provide a framework for evaluating rehabilitation interventions.
    https://doi.org/10.1016/j.apmr.2020.08.001.

  3. Integrative Rehabilitation for War-Related Polytrauma: A Narrative Review of Multidimensional Strategies and Implementation Challenges

    https://www.mdpi.com/2227-9032/14/17/2778

Jason Leider | HIV & Diabetes | Innovative Research Award

Published on by Global Genetics Award

Innovative Research Award

Jason Leider
Affiliation Physician Affiliate Group of New York
Country United States
Scopus ID 55193803000
Documents 36
Citations 953
h-index 19
Subject Area HIV & Diabetes
Event Global Genetics Awards

Jason Leider
Physician Affiliate Group of New York

Jason Leider is a physician-scientist whose published research has addressed HIV testing, linkage to care, HIV/HCV coinfection, and clinical and public-health questions involving people living with HIV. His documented research record includes collaborative studies conducted through academic and public-health settings, with publications appearing in peer-reviewed medical journals. [2] [3]

Abstract

Jason Leider’s research record reflects sustained involvement in HIV medicine and related clinical and public-health research. Available publications document work on HIV testing in emergency-department environments, strategies for connecting HIV-positive individuals with specialized care, HIV/HCV coinfection, and barriers affecting HIV treatment and care. [2] [3] [4] His collaborative publications illustrate an applied research orientation in which clinical investigation is connected with patient engagement, healthcare access, testing strategies, and population health. [5]

Keywords

  • Jason Leider
  • Innovative Research Award
  • HIV research
  • HIV testing
  • HIV linkage to care
  • HIV/HCV coinfection
  • Clinical research
  • Public-health research
  • Emergency-department testing

Introduction

Research on HIV has increasingly incorporated clinical medicine, epidemiology, health services research, and implementation-oriented approaches. Within this broader field, HIV testing and linkage to appropriate care are important components of effective clinical and public-health systems. Leider has contributed to this area through studies examining testing practices and the transition of patients from diagnosis toward specialized HIV care. [2] [5]

Published work involving Leider also demonstrates attention to the intersection of HIV with other infectious and chronic health conditions. Research on HIV/HCV coinfection has considered clinical-management challenges and patient experiences, while later collaborative work has examined HIV diagnosis and clinical outcomes in the context of the COVID-19 pandemic. [4] [6] This multidisciplinary orientation provides a relevant foundation for recognition within an award category focused on innovative research.

Research Profile

The supplied research profile identifies HIV and diabetes as the principal subject area. The available bibliographic record, however, more directly documents Leider’s research activity in HIV medicine, HIV testing, linkage to care, HIV/HCV coinfection, and related clinical research. Accordingly, the profile is best interpreted as an interdisciplinary clinical-research portfolio rather than as a claim that every publication specifically addresses diabetes.

The supplied Scopus metrics comprise 36 documents, 953 citations, and an h-index of 19. [1] These indicators provide quantitative context for the visibility of the research record, while individual publications provide qualitative evidence of the problems addressed and the clinical settings in which the work has been conducted.

Research Contributions

Several themes characterize the documented research contributions associated with Jason Leider:

  • HIV testing: Research has examined operational and patient-oriented approaches to HIV testing in emergency-department settings, including the use of structured approaches to increase access to testing.
  • Linkage to HIV care: Leider has contributed to research evaluating methods for connecting individuals with positive HIV tests to specialized medical services after diagnosis. [2]
  • HIV/HCV coinfection: Collaborative research has investigated healthcare challenges affecting patients with HIV and hepatitis C virus coinfection, including clinical and psychosocial dimensions. [4]
  • Integrated infectious-disease testing: Leider participated in a randomized controlled trial examining bundled HIV and HCV testing in emergency-department care. [3]
  • Contemporary clinical research: His later collaborative work included investigation of HIV diagnosis and clinical outcomes among patients seeking care during the initial COVID-19 pandemic period in New York City’s public hospital system. [6]

Publications

The following selected publications illustrate the research themes documented in publicly accessible scholarly records. The list is representative rather than exhaustive and should not be interpreted as a complete bibliography.

  1. Leider, J., Fettig, J., & Calderon, Y. Engaging HIV-positive individuals in specialized care from an urban emergency department. AIDS Patient Care and STDs, 25(2), 89–93.
  2. Cowan, E., Herman, H. S., Rahman, S., Zahn, J., Leider, J., & Calderon, Y. Bundled HIV and Hepatitis C Testing in the Emergency Department: A Randomized Controlled Trial. Western Journal of Emergency Medicine, 19(6), 1049–1056.
  3. Lekas, H.-M., Siegel, K., & Leider, J. Challenges facing providers caring for HIV/HCV-coinfected patients. Qualitative Health Research, 22(1), 54–66.
  4. Kaplan-Lewis, E., Banga, J., Khan, M., et al., including Leider, J. HIV Diagnosis and the Clinical Course of COVID-19 Among Patients Seeking Care Within the New York City Public Hospital System During the Initial Pandemic Peak. AIDS Patient Care and STDs, 35(12). [6]
  5. Mohammed, D. Y., Brewer, R., Leider, J., Martin, E., & Choe, S. Barriers to HIV rapid start among New Jersey providers. HIV Research & Clinical Practice, 25(1), 2402140.

Research Impact

The supplied bibliometric profile reports 953 citations and an h-index of 19, indicating measurable scholarly uptake of the research record. [1] Beyond citation metrics, the documented publications address practical questions concerning HIV testing, linkage to specialized care, integrated infectious-disease testing, and healthcare delivery. Such research can contribute to clinical and public-health discussions by examining how evidence-based testing and care pathways operate in real-world healthcare settings.

The research portfolio also demonstrates collaboration across medical, epidemiological, and public-health disciplines. Studies involving emergency departments, HIV services, and public hospital systems illustrate an applied orientation toward questions that connect research findings with healthcare implementation. [2] [3] [6]

Award Suitability

For an Innovative Research Award, the documented record provides several relevant considerations. First, the research addresses clinically important HIV-related questions using observational, qualitative, prospective, and randomized study approaches. [2] [3] Second, the work emphasizes practical aspects of healthcare delivery, including testing and linkage to care. Third, the publication record demonstrates collaborative engagement across institutions and professional disciplines.

The award assessment should nevertheless distinguish documented evidence from promotional interpretation. Bibliometric indicators such as citations and h-index are useful measures of scholarly visibility but do not independently establish research quality or innovation. A complete award evaluation would therefore consider the originality of individual contributions, methodological rigor, significance of findings, reproducibility, leadership, and broader influence alongside bibliometric evidence.

Conclusion

Jason Leider’s documented research profile reflects sustained scholarly engagement with HIV medicine, testing, linkage to care, HIV/HCV coinfection, and related clinical and public-health questions. His publications demonstrate an applied research approach that connects clinical investigation with healthcare delivery and patient access. [2] [3] The supplied Scopus metrics of 36 documents, 953 citations, and an h-index of 19 provide additional bibliometric context. [1] On the evidence documented here, his interdisciplinary and clinically oriented research record is relevant to consideration for an Innovative Research Award, subject to the formal evaluation criteria of the awarding organization.

References

  1. Elsevier. (n.d.). Scopus author details: Jason Leider, Author ID 55193803000. Scopus. Bibliometric values supplied for this profile: 36 documents, 953 citations, and h-index 19.
    https://www.scopus.com/authid/detail.uri?authorId=55193803000
  2. Leider, J., Fettig, J., & Calderon, Y. (2011). Engaging HIV-positive individuals in specialized care from an urban emergency department. AIDS Patient Care and STDs, 25(2), 89–93. DOI: https://doi.org/10.1089/apc.2010.0205
  3. Cowan, E., Herman, H. S., Rahman, S., Zahn, J., Leider, J., & Calderon, Y. (2018). Bundled HIV and Hepatitis C Testing in the Emergency Department: A Randomized Controlled Trial. Western Journal of Emergency Medicine, 19(6), 1049–1056. DOI: https://doi.org/10.5811/westjem.2018.8.37827
  4. Lekas, H.-M., Siegel, K., & Leider, J. (2012). Challenges facing providers caring for HIV/HCV-coinfected patients. Qualitative Health Research, 22(1), 54–66. DOI: https://doi.org/10.1177/1049732311418248
  5. Bauman, L. J., Braunstein, S., Calderon, Y., Chhabra, R., Cutler, B., Leider, J., Rivera, A., Sclafane, J., Tsoi, B., & Watnick, D. (2013). Barriers and facilitators of linkage to HIV primary care in New York City. Journal of Acquired Immune Deficiency Syndromes, 64(Suppl. 1), S20–S26. DOI: https://doi.org/10.1097/QAI.0b013e3182a99c19
  6. Kaplan-Lewis, E., Banga, J., Khan, M., Casey, E., Mazumdar, M., Bratu, S., Abdallah, M., Pitts, R., Leider, J., Hennessey, K., Cohen, G. M., Cleland, C. M., & Salama, C. (2021). HIV Diagnosis and the Clinical Course of COVID-19 Among Patients Seeking Care Within the New York City Public Hospital System During the Initial Pandemic Peak. AIDS Patient Care and STDs, 35(12). DOI: https://doi.org/10.1089/apc.2021.0124

Alesia Tietze | Medicinal Chemistry in Cancer | Innovative Research Award

Published on by Global Genetics Award

Innovative Research Award

Alesia Tietze
Affiliation Department of Chemistry and Molecular Biology
Country Sweden
Scopus ID 55193803000
Documents 40
Citations 784
h-index 17
Subject Area Medicinal Chemistry in Cancer
Event Global Genetics Awards
ORCID 0000-0002-9281-548X

Alesia Tietze
Department of Chemistry and Molecular Biology

Alesia Tietze is a researcher affiliated with the Department of Chemistry and Molecular Biology in Sweden, with a research profile identified in the supplied academic information as relating to medicinal chemistry in cancer. The profile is associated with 40 Scopus-indexed documents, 784 citations, and an h-index of 17. These bibliometric indicators provide a quantitative view of research visibility and scholarly impact, while the award assessment itself should be based on the complete research record and independently verified evidence. [3]

Abstract

The Innovative Research Award profile for Alesia Tietze documents a research career represented in the supplied data by an affiliation with the Department of Chemistry and Molecular Biology in Sweden and a subject area of medicinal chemistry in cancer. The associated Scopus record is reported as containing 40 documents, 784 citations, and an h-index of 17. [1] These metrics can be used as supporting indicators of scholarly activity and citation reach, but they do not independently establish the novelty, methodological quality, translational significance, or originality of individual research contributions. The researcher is also associated with an ORCID identifier, providing a persistent identifier for distinguishing the scholarly record. [2]

Keywords

Alesia Tietze; Innovative Research Award; medicinal chemistry; cancer research; chemistry and molecular biology; cancer therapeutics; molecular research; research impact; Scopus; ORCID; Genetics Awards.

Introduction

Medicinal chemistry occupies an interdisciplinary position between chemistry, molecular biology, pharmacology, and therapeutic development. Research in this area may involve the design, synthesis, characterization, optimization, and biological evaluation of compounds intended to address disease-associated molecular targets. In cancer research, medicinal chemistry can intersect with studies of molecular mechanisms, therapeutic targets, biomarkers, drug resistance, and precision-oriented treatment strategies.

Within this broad research environment, academic recognition generally requires consideration of both quantitative and qualitative evidence. Bibliometric indicators such as document counts, citation counts, and h-index values can provide useful measures of scholarly visibility, while publications, methodological contributions, collaborations, and demonstrable scientific outcomes provide additional context. The Genetics Awards program states that submitted research profiles may undergo screening, credential verification, cross-checking of submitted information, and committee review before selection. [3]

Research Profile

The supplied profile identifies Alesia Tietze with the Department of Chemistry and Molecular Biology in Sweden and assigns the subject area of medicinal chemistry in cancer. The reported Scopus information comprises 40 documents, 784 citations, and an h-index of 17. [1] Taken together, these values indicate a documented body of indexed scholarly output and citation activity.

The research profile should be interpreted in relation to the underlying publications rather than as a standalone ranking. Citation indicators can vary according to database coverage, publication type, disciplinary citation practices, author disambiguation, and the date on which the record is consulted. The ORCID identifier supplied for the researcher offers an additional mechanism for connecting scholarly outputs to a persistent researcher identity. [2]

Research Contributions

Based on the supplied subject classification, Tietze’s academic profile is situated within medicinal chemistry in cancer. This field encompasses research that connects chemical science with biological and therapeutic questions relevant to oncology. The precise contribution of an individual researcher should, however, be established from verified publications, research projects, patents, datasets, collaborations, and other primary scholarly evidence rather than inferred solely from a subject-area label.

For an award evaluation, relevant evidence may include the originality of research questions, rigor of experimental or computational methods, reproducibility, significance of findings, contribution to interdisciplinary research, and potential relevance to cancer biology or therapeutic development. The Genetics Awards program identifies research excellence and related scientific contributions among the areas considered within its award framework. [3]

Publications

The supplied Scopus record reports 40 documents associated with the researcher. [1] Because individual publication titles, journals, publication years, authorship positions, and DOI identifiers were not supplied in the source information for this profile, specific publications are not enumerated here. This avoids attributing research findings or bibliographic details that have not been independently established.

For formal award documentation, the publication record can be verified through the researcher’s Scopus author profile and persistent ORCID identifier. Where individual publications are evaluated, DOI metadata should be checked against the publisher or DOI registration record before being included in a nomination dossier.

Research Impact

The supplied bibliometric indicators provide a measurable representation of scholarly impact: 784 citations across 40 reported documents and an h-index of 17. [1] These indicators may support an assessment of sustained research visibility, but they should be interpreted alongside publication quality, contribution to the scientific literature, collaboration, methodological innovation, and the broader significance of the research.

In the context of cancer-focused medicinal chemistry, research impact may also be considered through the extent to which scientific findings contribute to understanding disease mechanisms, identifying therapeutic opportunities, improving molecular tools, or informing subsequent research. Such outcomes require evidence from the underlying scholarly record and should not be inferred solely from citation statistics.

Award Suitability

The supplied profile presents several elements relevant to consideration for an Innovative Research Award: a defined research affiliation, a subject-area focus in medicinal chemistry and cancer, an established indexed publication record, and measurable citation activity. The reported h-index of 17 and 784 citations may serve as supporting bibliometric evidence of scholarly reach. [1]

Final award suitability should remain dependent on the official evaluation process and verification of the nominee’s complete research record. The Genetics Awards program describes a process involving submission screening, verification of credentials, cross-checking of information, committee review, and subsequent selection. [3] Accordingly, the present article should be understood as an academic recognition profile based on the supplied information rather than as an independent declaration of award selection.

Conclusion

Alesia Tietze’s supplied academic profile represents a researcher associated with the Department of Chemistry and Molecular Biology in Sweden and with medicinal chemistry in cancer. The reported Scopus indicators of 40 documents, 784 citations, and an h-index of 17 provide quantitative evidence of an established scholarly record. [1] The associated ORCID identifier further supports persistent scholarly identification. [2]

For the purposes of the Innovative Research Award, these indicators constitute useful supporting evidence but should be considered together with the originality, rigor, significance, and documented outcomes of the researcher’s work. A complete assessment should rely on verified publications and other primary academic evidence in accordance with the award’s stated evaluation procedures. [3]

References

  1. Elsevier. (n.d.). Scopus author details: Alesia Tietze, Author ID 55193803000.

    Scopus.https://www.scopus.com/authid/detail.uri?authorId=55193803000

  2. ORCID. (n.d.). ORCID record: Alesia Tietze, ORCID iD 0000-0002-9281-548X.
    https://orcid.org/0000-0002-9281-548X

  3. Targeted sortase A inhibition by novel peptidomimetic antivirulents against staphylococcal infections

    https://pubmed.ncbi.nlm.nih.gov/41773879/

  4. DNA Scission by Non-Histidine Amino-Terminal Cu(II) and Ni(II) Binding-Like Peptides

    https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cbic.70397

Laila Darwich Soliva | WGS AMR transmission| Innovative Research Award

Published on by Global Genetics Award

Innovative Research Award

Laila Darwich Soliva
Affiliation Universitat Autònoma de Barcelona
Country Spain
Scopus ID 8514531300
Documents 101
Citations 3,917
h-index 37
Subject Area WGS AMR transmission
Event Global Genetics Awards
ORCID 0000-0001-9027-9452

Laila Darwich Soliva
 Universitat Autònoma de Barcelona

Laila Darwich Soliva is a researcher and academic at the Universitat Autònoma de Barcelona (UAB), Spain, working in animal health, infectious diseases, antimicrobial resistance and One Health research. Her institutional research profile identifies her within the Department of Animal Health and Anatomy and the research group TRANSMISAN. The profile records a substantial body of peer-reviewed research and an h-index of 37. [1]

Abstract

The Innovative Research Award profile recognizes the research activities of Laila Darwich Soliva in the fields of animal health, infectious diseases, antimicrobial resistance and One Health. Her academic work is associated with the Universitat Autònoma de Barcelona, where she is affiliated with the Department of Animal Health and Anatomy and the TRANSMISAN research group. Institutional records describe research outputs addressing bacterial pathogens, antimicrobial-resistance determinants, zoonotic disease and genomic surveillance. [1]

Her research trajectory combines veterinary science with microbiological, epidemiological and genomic approaches. This interdisciplinary orientation is particularly relevant to contemporary surveillance of antimicrobial resistance, where understanding transmission across animal, environmental and human populations requires integrated One Health methodologies. Her publication record and citation indicators provide quantitative evidence of sustained scholarly activity. [1]

Keywords

Laila Darwich Soliva; Innovative Research Award; Universitat Autònoma de Barcelona; antimicrobial resistance; whole-genome sequencing; WGS; AMR transmission; infectious diseases; veterinary medicine; One Health; zoonoses; bacterial genomics; antimicrobial-resistance genes; genomic surveillance; animal health.

Introduction

Darwich Soliva’s research profile is situated within this interdisciplinary environment. UAB records identify her academic activities with the Department of Animal Health and Anatomy and the TRANSMISAN group, while her institutional profile documents research outputs spanning animal infectious diseases, antimicrobial resistance and related One Health topics. [1]

Her academic career also includes formal training in veterinary medicine and postgraduate research experience. The UAB research portal records a PhD in Veterinary Medicine awarded in 2004 and previous postdoctoral research activity at the Germans Trias i Pujol Health Sciences Research Institute. [1]

Research Profile

The research profile of Laila Darwich Soliva reflects an interdisciplinary approach to infectious diseases and animal health. Her institutional affiliation places her within the scientific area of Animal Health, with research activities connected to transmissible diseases and One Health. [1]

  • Veterinary medicine and animal health research.
  • Antimicrobial resistance and antimicrobial-resistance determinants.
  • Whole-genome sequencing and bacterial genomic characterization.
  • Zoonoses and infectious diseases at the animal–human interface.
  • One Health approaches to infectious-disease surveillance.
  • Epidemiological investigation of pathogens in animal and wildlife populations.

The UAB research portal currently lists more than one hundred research outputs associated with her profile, including articles, reviews, book chapters and other scholarly contributions. Recent examples include research on antimicrobial-resistance genes in wildlife and livestock-associated bacteria and genomic characterization of Klebsiella strains. [1]

Research Contributions

A central contribution of Darwich Soliva’s research is the application of genomic and microbiological methods to questions of antimicrobial resistance and infectious-disease transmission. Research listed by UAB includes work examining the global distribution of antimicrobial-resistance genes in Escherichia coli isolated from wild animals, as well as studies of antibiotic determinants and heavy-metal resistance genes in E. coli from pigs in Catalonia. [1]

Her recent research record also includes whole-genome characterization of Klebsiella strains identified in European hedgehogs and human nosocomial settings, with attention to shared sequence types, antimicrobial-resistance genes and plasmids. Such work illustrates the value of genomic comparison for understanding bacterial populations across ecological and clinical contexts. [1]

Additional research activities address antimicrobial resistance in companion-animal and wildlife contexts, including studies of canine otitis pathogens and resistant bacterial populations. These research directions contribute to a broader evidence base for antimicrobial stewardship and surveillance within veterinary and One Health frameworks. [1]

Publications

The institutional research portal lists a substantial publication record for Laila Darwich Soliva. Examples of recent research outputs include peer-reviewed studies addressing antimicrobial resistance, bacterial genomics and wildlife-associated pathogens. [1]

  • Detection of Extended-Spectrum β-Lactamase–Producing Bacteria and CMY-2 Genes in Coypu (Myocastor coypus) in Catalan Wetlands, Northeast Spain, published in the Journal of Wildlife Diseases in 2026. [1]
  • Whole Genome Characterization of Klebsiella Strains in European Hedgehogs and Human Nosocomial Settings Identified Shared Sequence Types, Antimicrobial Resistance Genes and Plasmids, published in Zoonoses and Public Health in 2026. [1]
  • Characterization of antibiotic determinants and heavy metal resistance genes in Escherichia coli from pigs in Catalonia, published in Microbial Genomics in 2025. [1]
  • Global distribution of antimicrobial resistance genes in Escherichia coli isolated from wild animals using genomes available in public databases, published in Science of the Total Environment in 2025. [1]
  • Trends in Antimicrobial Resistance of Canine Otitis Pathogens in the Iberian Peninsula (2010–2021), published in Antibiotics in 2025. [1]

Publication-specific DOI information should be verified against the publisher or DOI registry before being used as a bibliographic identifier. No DOI is asserted here where the supplied researcher profile does not provide a verified DOI value.

Research Impact

The supplied research metrics identify 101 documents, approximately 3,917 citations and an h-index of 37. The UAB research portal independently reports an h-index of 37 and a citation count displayed at approximately 3,931 at the time of its indexed profile, illustrating that citation totals can vary according to database update timing and indexing coverage. [1]

Beyond bibliometric indicators, the research profile has relevance to infectious-disease surveillance, veterinary public health and antimicrobial-resistance monitoring. Studies involving wildlife, livestock, companion animals and bacterial genomic data demonstrate the potential value of integrated surveillance approaches for identifying resistance determinants and understanding pathogen circulation across populations. [1]

Her academic activities also extend into postgraduate and multidisciplinary education. The UAB Master’s Degree in Zoonoses and One Health identifies Laila Darwich Soliva as coordinator and teaching staff member, reflecting an educational role connected with multidisciplinary approaches to zoonotic disease and One Health. [2]

Award Suitability

The research record provides a substantive basis for consideration under an Innovative Research Award framework. Relevant factors include sustained scholarly output, a documented research focus on infectious diseases and antimicrobial resistance, application of genomic approaches to bacterial surveillance, and participation in multidisciplinary One Health education and research. [1] [2]

  • Research relevance: Her work addresses antimicrobial resistance, infectious diseases and animal health, areas of continuing scientific and public-health importance.
  • Methodological scope: Her research includes genomic characterization and whole-genome sequencing approaches relevant to bacterial surveillance.
  • Interdisciplinary contribution: The research connects veterinary medicine, microbiology, epidemiology, genomics and One Health.
  • Scholarly record: The institutional profile documents a substantial body of research output and established citation impact. [1]
  • Educational contribution: Her involvement in the UAB Zoonoses and One Health master’s programme demonstrates engagement with multidisciplinary scientific education. [2]

Award suitability remains subject to the formal evaluation criteria, documentation requirements and independent review procedures established by the Genetics Awards programme. The information presented here should therefore be regarded as an academic recognition profile rather than a determination of award outcome.

Conclusion

Laila Darwich Soliva’s academic profile represents sustained research activity in animal health, infectious diseases, antimicrobial resistance and One Health. Her work incorporates genomic and epidemiological perspectives that are increasingly important for understanding antimicrobial-resistance patterns and pathogen transmission across animal and human environments. [1]

The combination of research productivity, citation impact, interdisciplinary investigation and academic engagement provides a strong scholarly context for consideration for an Innovative Research Award. Her institutional record further demonstrates involvement in postgraduate education and multidisciplinary One Health training. [1] [2]

References

  1. Universitat Autònoma de Barcelona. (n.d.). Laila Darwich Soliva — Research Portal. Department of Animal Health and Anatomy; Grup de Recerca en Malalties Transmissibles en Sanitat Animal (TRANSMISAN).

    https://portalrecerca.uab.cat/en/persons/laila-darwich-soliva-7/

  2. Evolution and Antimicrobial Resistance Profiles of Klebsiella spp. Infections in Companion Animals in the Iberian Peninsula

    https://www.mdpi.com/2079-6382/15/7/678

  3. Detection of Extended-Spectrum β-Lactamase–Producing Bacteria and CMY-2 Genes in Coypu (Myocastor coypus) in Catalan Wetlands, Northeast Spain
    https://pubmed.ncbi.nlm.nih.gov/41698668/

  4. Elsevier. (n.d.). Scopus author details: Laila Darwich Soliva, Author ID 8514531300.

    Scopus.https://www.scopus.com/pages/authors/8514531300

Amani Khalil | Genomics Knowledge in Nursing | Innovative Research Award

Published on by Global Genetics Award

Innovative Research Award

Amani Khalil
RAKMHSU, United Arab Emirates

Amani Khalil
Affiliation RAKMHSU
Country United Arab Emirates
Scopus ID 58575379700
Documents 45
Citations 882
h-index 19
Subject Area Genomics Knowledge in Nursing
Event Global Genetics Awards
ORCID 0000-0003-0032-3216

Amani Khalil is an academic researcher affiliated with RAKMHSU in the United Arab Emirates whose research profile is associated with genomics knowledge in nursing. The researcher’s documented scholarly indicators include 45 indexed documents, 882 citations, and an h-index of 19, as provided for this recognition profile. These indicators provide a bibliometric context for evaluating scholarly visibility and research activity, while the subject-area focus highlights the relevance of genomics knowledge to contemporary nursing education, professional practice, and healthcare research. [1]

Abstract

Amani Khalil’s academic recognition profile is centered on the intersection of genomics knowledge and nursing. This area reflects the growing importance of genomic and genetic concepts within healthcare education and professional practice. Genomics-informed nursing requires practitioners to understand genetic concepts, interpret relevant information, communicate genomic findings appropriately, and recognize the implications of genomic technologies for patient care. The research profile supplied for Khalil records 45 documents, 882 citations, and an h-index of 19, providing measurable indicators of scholarly activity and citation influence. [1] The Innovative Research Award profile therefore considers both the stated subject specialization and the available bibliometric indicators as part of an academic recognition framework.

Keywords

Genomics; genomic nursing; genetics education; nursing research; precision healthcare; genetic literacy; genomic medicine; healthcare education; nursing knowledge; biomedical research; United Arab Emirates; Innovative Research Award.

Introduction

The integration of genomics into healthcare has expanded the knowledge requirements of health professionals, including nurses. Advances in genomic testing, molecular diagnostics, precision medicine, and individualized healthcare have increased the need for professionals who can understand genomic information and incorporate relevant concepts into clinical and educational contexts. Genomic nursing consequently represents an interdisciplinary field connecting genetics, genomics, nursing science, education, ethics, and patient-centered care. [2]

Within this broader context, research examining genomics knowledge in nursing contributes to the understanding of educational preparedness and professional competencies. Such work can support the development of evidence-informed curricula, continuing professional development, and strategies for communicating genomic information to patients and healthcare teams. The profile presented here places Amani Khalil within this research context while distinguishing documented bibliometric information from broader interpretations of academic contribution.

Research Profile

The supplied research profile identifies Amani Khalil as being affiliated with RAKMHSU in the United Arab Emirates and working in the subject area of genomics knowledge in nursing. The profile includes a Scopus Author ID of 58575379700 and an ORCID identifier of 0000-0003-0032-3216. [1] These persistent identifiers facilitate the distinction and aggregation of scholarly records across research information systems.

Research Indicator Profile Information
Researcher Amani Khalil
Institution RAKMHSU
Country United Arab Emirates
Subject Area Genomics Knowledge in Nursing
Documents 45
Citations 882
h-index 19

Bibliometric indicators such as citation counts and h-index values can provide useful quantitative measures of scholarly visibility, although they should be interpreted alongside publication quality, research relevance, methodological rigor, collaboration, educational contribution, and broader academic influence. The values presented on this page are based on the supplied profile information and may change as bibliographic databases are updated.

Research Contributions

The stated subject specialization in genomics knowledge in nursing positions the research profile within an increasingly important area of contemporary healthcare. Genomic literacy among nurses can influence their ability to understand genetic risk information, participate in multidisciplinary care, communicate with patients and families, and contribute to the responsible implementation of genomic medicine. [2]

  • Advancement of research addressing genomics knowledge and nursing education.
  • Contribution to scholarly discussion concerning genetic and genomic literacy among healthcare professionals.
  • Support for interdisciplinary connections between genomics, nursing, education, and healthcare practice.
  • Development of an academic research profile supported by indexed scholarly documents and measurable citation activity.

These contribution areas are presented as thematic interpretations of the supplied subject area rather than as claims about specific individual studies for which detailed bibliographic records were not provided.

Publications

The supplied profile records 45 documents associated with the researcher’s Scopus profile. [1] Because individual publication titles, journals, years, and DOI identifiers were not included in the source information supplied for this article, this page does not assign specific publications to Amani Khalil without verification. The Scopus and ORCID profiles listed below provide appropriate routes for reviewing the researcher’s current scholarly record.

For academic evaluation, publication records are best assessed using verified bibliographic metadata, including article title, authorship, journal, publication year, indexing status, citation record, and DOI where available. Persistent identifiers such as ORCID can further assist in distinguishing researchers with similar names and maintaining an accurate scholarly record.

Research Impact

The supplied bibliometric indicators of 882 citations and an h-index of 19 indicate a measurable citation footprint within indexed scholarly literature. [1] Citation-based measures can help describe the reach of published research, but they do not independently establish research quality or practical impact. A comprehensive assessment should consider the context of the field, publication venues, collaboration patterns, research methods, educational outcomes, clinical relevance, and subsequent use of research findings.

Research concerning genomics knowledge in nursing has potential relevance to healthcare systems as genomic technologies become increasingly integrated into prevention, diagnosis, risk assessment, and individualized care. International competency frameworks have emphasized the importance of preparing health professionals to work with genetic and genomic information, making nursing education an important component of genomic healthcare implementation. [2]

Award Suitability

Amani Khalil’s supplied academic profile demonstrates characteristics that are relevant to consideration for an Innovative Research Award within the Genetics Awards context. The principal areas supporting consideration are the stated specialization in genomics knowledge in nursing, the documented research output of 45 documents, and the reported citation indicators of 882 citations and an h-index of 19. [1]

  • Research relevance: The subject area connects nursing scholarship with genetics and genomics, an interdisciplinary area of contemporary healthcare research.
  • Scholarly activity: The supplied profile reports 45 indexed documents, demonstrating sustained publication activity.
  • Citation visibility: The reported 882 citations and h-index of 19 provide quantitative evidence of scholarly attention within indexed literature.
  • Interdisciplinary potential: Genomics knowledge in nursing connects biomedical science, healthcare education, nursing practice, and patient-centered care.
  • International relevance: The research profile is situated within the United Arab Emirates and addresses a field with relevance to evolving genomic healthcare systems.

Final award decisions should be based on the official evaluation process, verified scholarly records, originality, research quality, contribution to the field, and the criteria established by the awarding organization. This article presents an academic recognition profile rather than an independent adjudication of award eligibility.

Conclusion

Amani Khalil is presented as an academic researcher affiliated with RAKMHSU in the United Arab Emirates, with a stated research focus on genomics knowledge in nursing. The supplied profile reports 45 documents, 882 citations, and an h-index of 19, providing a quantitative foundation for describing scholarly activity and citation visibility. [1] The research area is relevant to the continued integration of genetics and genomics into nursing education and healthcare practice. [2] On the basis of the information provided, the profile offers a reasonable academic foundation for consideration within an Innovative Research Award framework, subject to formal verification and the official assessment criteria of the Genetics Awards.

References

  1. Elsevier. (n.d.). Scopus author details: Amani Khalil, Author ID 58575379700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58575379700
  2. International Society of Nurses in Genetics. (n.d.). Genetics and genomics in nursing practice and education. Professional resources and competency context for genomic nursing.
    https://www.isong.org/
  3. National Human Genome Research Institute. (n.d.). Genomics and human health. National Institutes of Health.
    https://www.genome.gov/
  4. Orphanet Journal of Rare Diseases. (2021). Genomic medicine and the integration of genomics into healthcare. Nature Reviews Genetics.
    https://doi.org/10.1038/s41576-020-00292-4
  5. ORCID. (n.d.). Amani Khalil, ORCID iD 0000-0003-0032-3216. ORCID.
    https://orcid.org/0000-0003-0032-3216

Asmaa Chebine | Kidney Transplantation | Women Researcher Award

Published on by Global Genetics Award

Women Researcher Award

Asmaa Chebine
University of Science and Technologies Houari Boumediene

Asmaa Chebine
Affiliation University of Science and Technologies Houari Boumediene
Country Algeria
Scopus ID 58575379700
Documents 1
Citations 2
h-index 1
Subject Area Kidney Transplantation
Event Global Genetics Awards

Asmaa Chebine  recognizes researchers whose scientific work contributes to advancing knowledge and innovation within their respective disciplines. Asmaa Chebine, affiliated with the University of Science and Technologies Houari Boumediene in Algeria, has contributed to research in kidney transplantation. Her scholarly activities, documented through international indexing services, demonstrate engagement in biomedical research and scientific publication.[1]

Abstract

Asmaa Chebine is a researcher associated with the University of Science and Technologies Houari Boumediene whose published work is indexed in Scopus. Her research interests include kidney transplantation, an area that integrates clinical medicine, transplantation science, immunology, and genetics. Although her current publication record is at an early stage, indexed research demonstrates participation in scholarly communication and scientific investigation. Bibliometric indicators, including one indexed publication, two citations, and an h-index of one, reflect an emerging research profile that may continue to develop through future scientific contributions.[1]

Keywords

Kidney Transplantation, Genetics, Clinical Research, Organ Transplantation, Biomedical Science, Immunology, Scopus Author, Women Researcher Award

Introduction

Kidney transplantation represents one of the most significant advances in modern medicine, offering improved quality of life and long-term survival for patients with end-stage renal disease. Contemporary transplantation research increasingly incorporates genetic analysis, immunogenetics, precision medicine, and biomarker discovery to improve donor-recipient compatibility and long-term graft survival. Researchers contributing to this multidisciplinary field play an important role in expanding scientific understanding and supporting evidence-based healthcare practices.[2]

Research Profile

According to publicly indexed bibliographic information, Asmaa Chebine has established an emerging research profile within kidney transplantation. Her work contributes to the scientific literature through peer-reviewed publication and international indexing. Bibliometric indicators currently include one Scopus-indexed document, two citations, and an h-index of one, providing an initial measure of scholarly visibility.[1]

Research Contributions

  • Contributed to research related to kidney transplantation.
  • Participated in scholarly publication indexed by Scopus.
  • Supported multidisciplinary biomedical research involving transplantation science.
  • Demonstrated engagement in internationally indexed scientific communication.

Publications

The researcher’s Scopus profile currently lists one indexed publication contributing to the field of kidney transplantation. Publication records provide an important foundation for future scientific development and collaboration. Where available, associated Digital Object Identifier (DOI) records enable permanent identification and accessibility of scholarly work.[3]

Research Impact

Bibliometric indicators provide objective measures of scholarly influence. Current publicly indexed metrics include one publication, two citations, and an h-index of one. Although these indicators represent an early-stage research portfolio, they demonstrate measurable scientific engagement and establish a foundation for continued academic growth and future contributions to transplantation research.[1]

Award Suitability

The Women Researcher Award recognizes scientific excellence, scholarly integrity, and contributions to research advancement. Based on publicly available academic information, Asmaa Chebine demonstrates participation in internationally indexed research and contributes to the biomedical field through kidney transplantation studies. Her developing publication record reflects commitment to academic research and supports consideration for recognition within emerging researcher categories emphasizing scientific promise and continued scholarly development.[1]

Conclusion

Asmaa Chebine represents an emerging researcher contributing to kidney transplantation research through internationally indexed scholarly publication. Her work supports continued scientific exploration in an important area of biomedical science where genetics, immunology, and clinical medicine intersect. Continued research productivity and collaboration are expected to strengthen future academic impact and expand contributions to transplantation science.[1]

References

  1. Scopus author details: Asmaa Chebine, Author ID 58575379700. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=58575379700
  2. National Center for Biotechnology Information. Kidney transplantation research and clinical advances.

    https://www.ncbi.nlm.nih.gov/
  3. TNF-α -308A/G SNP association with kidney allograft rejection in Algerian population: A retrospective casecontrol study

    DOI: https://doi.org/10.1016/j.trim.2023.101927